Women vaccinated with one dose of a human papillomavirus (HPV) vaccine had antibodies against the viruses that remained stable in their blood for four years, suggesting that a single dose of vaccine may be sufficient to generate long-term immune responses and protection against new HPV infections, and ultimately cervical cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Read more:
One Dose of HPV Vaccine May Be Enough to Prevent Cervical Cancer
Source: American Association for Cancer Research
Image credits:
Cure talk
______________________________________________________________
Quality and Education Services
for Medical Laboratories and POCT
______________________________________________________________
Follow Art and Science of Laboratory Medicine on
______________________________________________________________
